| Title |
In-vivo-validation of a cardiovascular risk prediction tool: the arriba-pro study
|
|---|---|
| Published in |
BMC Primary Care, January 2013
|
| DOI | 10.1186/1471-2296-14-13 |
| Pubmed ID | |
| Authors |
Annette Diener, Salomé Celemín-Heinrich, Karl Wegscheider, Kai Kolpatzik, Katrin Tomaschko, Attila Altiner, Norbert Donner-Banzhoff, Jörg Haasenritter |
| Abstract |
Calculation of individual risk is the cornerstone of effective cardiovascular prevention. arriba is a software to estimate the individual risk to suffer a cardiovascular event in 10 years. Prognosis and the absolute effects of pharmacological and lifestyle interventions help the patient make a well-informed decision. The risk calculation algorithm currently used in arriba is based on the Framingham risk algorithm calibrated to the German setting. The objective of this study is to evaluate and adapt the algorithm for the target population in primary care in Germany. |
Mendeley readers
The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 2% |
| Unknown | 50 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 12 | 24% |
| Student > Ph. D. Student | 8 | 16% |
| Student > Bachelor | 7 | 14% |
| Student > Master | 4 | 8% |
| Student > Doctoral Student | 3 | 6% |
| Other | 7 | 14% |
| Unknown | 10 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 24 | 47% |
| Nursing and Health Professions | 5 | 10% |
| Social Sciences | 3 | 6% |
| Biochemistry, Genetics and Molecular Biology | 2 | 4% |
| Computer Science | 2 | 4% |
| Other | 5 | 10% |
| Unknown | 10 | 20% |